ruling on tirzepatide Update: December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On Circle - 🚨URGENT UPDATE: Compounded

Compare prices Ozempic prices can vary significantly between pharmacies

The results were clear-cut and statistically significant

It is noteworthy that Aldafermin has recently failed a Phase 2b ALPINE 2/3 study for NASH patients with stage 2 or 3 of liver fibrosis, but NGM Biopharmaceuticals are still evaluating this drug in a Phase 2b ALPINE 4 trial in NASH patients with severe fibrosis and compensated fibrosis

Cell Line Stability Stable cell clonality provides consistent expression of GLP-1 and related receptor targets High Sensitivity Optimized to detect subtle changes in receptor activity Scalable For HTS Our stable cell lines are fully validated to be HTS-ready, making it scalable with unparalleled efficiency No-Wash MULTISCREEN TM Assay Kits Streamlines experimental procedures by eliminating washing steps found in traditional assays, reducing time-cost and variability